A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

• P. Sandercock,
• E. Berge,
• M. Dennis,
• J. Forbes,
• P. Hand,
• J. Kwan,
• S. Lewis,
• R. Lindley,
• A. Neilson,
• B. Thomas,
• J. Wardlaw

Affiliations

P. Sandercock

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

E. Berge

Department of Internal Medicine, Ulleval Hospital, Oslo, Norway

M. Dennis

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

J. Forbes

Department of Public Health, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

P. Hand

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

J. Kwan

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

S. Lewis

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

R. Lindley

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

A. Neilson

HealthEcon, Basel, Switzerland

B. Thomas

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

J. Wardlaw

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland